PT  - JOURNAL ARTICLE
AU  - Siedner, Mark J.
AU  - Kraemer, John D.
AU  - Meyer, Mark J.
AU  - Harling, Guy
AU  - Mngomezulu, Thobeka
AU  - Gabela, Patrick
AU  - Dlamini, Siphephelo
AU  - Gareta, Dickman
AU  - Majozi, Nomathamsanqa
AU  - Ngwenya, Nothando
AU  - Seeley, Janet
AU  - Wong, Emily
AU  - Iwuji, Collins
AU  - Shahmanesh, Maryam
AU  - Hanekom, Willem
AU  - Herbst, Kobus
TI  - Access to primary healthcare during lockdown measures for COVID-19 in rural South Africa: a longitudinal cohort study
AID  - 10.1101/2020.05.15.20103226
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.15.20103226
4099  - http://medrxiv.org/content/early/2020/05/20/2020.05.15.20103226.short
4100  - http://medrxiv.org/content/early/2020/05/20/2020.05.15.20103226.full
AB  - Objectives Public health interventions designed to interrupt COVID-19 transmission could have deleterious impacts on primary healthcare access. We sought to identify whether implementation of the nationwide lockdown (shelter-in-place) order in South Africa affected ambulatory clinic visitation in rural Kwa-Zulu Natal (KZN).Design Prospective, longitudinal cohort studySetting Data were analyzed from the Africa Health Research Institute Health and Demographic Surveillance System, which includes prospective data capture of clinic visits at eleven primary healthcare clinics in northern KwaZulu-NatalParticipants A total of 36,291 individuals made 55,545 clinic visits during the observation period.Exposure of Interest We conducted an interrupted time series analysis with regression discontinuity methods to estimate changes in outpatient clinic visitation from 60 days before through 35 days after the lockdown period.Outcome Measures Daily clinic visitation at ambulatory clinics. In stratified analyses we assessed visitation for the following sub-categories: child health, perinatal care and family planning, HIV services, noncommunicable diseases, and by age and sex strata.Results We found no change in total clinic visits/clinic/day from prior to and during the lockdown (–6.9 visits/clinic/day, 95%CI –17.4, 3.7) or trends in clinic visitation over time during the lockdown period (–0.2, 95%CI –3.4, 3.1). We did detect a reduction in child healthcare visits at the lockdown (–7.2 visits/clinic/day, 95%CI –9.2, –5.3), which was seen in both children <1 and children 1–5. In contrast, we found a significant increase in HIV visits immediately after the lockdown (8.4 visits/clinic/day, 95%CI 2.4, 14.4). No other differences in clinic visitation were found for perinatal care and family planning, non-communicable diseases, or among adult men and women.Conclusions In rural KZN, the ambulatory healthcare system was largely resilient during the national-wide lockdown order. A major exception was child healthcare visitation, which declined immediately after the lockdown but began to normalize in the weeks thereafter. Future work should explore efforts to decentralize chronic care for high-risk populations and whether catch-up vaccination programs might be required in the wake of these findings.What is already known on this topic?Prior disease epidemics have created severe interruptions in access to primary care in sub-Saharan Africa, resulting in increased child and maternal mortalityData from resource-rich settings and modelling studies have suggested the COVID-19 epidemic and non-pharmacologic measures implemented in response could similarly result in substantial barriers to primary health care access in the regionWe leveraged a clinical information system in rural KwaZulu-Natal to empirically assess the effect of the COVID-19 epidemic and a nationwide lockdown in South Africa on access to primary careWhat this study adds?Access to primary healthcare was largely maintained during the most stringent period of the COVID-19 lockdown in South Africa, with the exception of a temporary drop in child health visitsCreative solutions are needed for sustaining child vaccination programs, and protecting high-risk individuals from risk of nosocomial transmission in resource-limited settingsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementWellcome Trust. 082384/Z/07/Z/. Willem Hanekom Wellcome Trust and Royal Society. 210479/Z/18/Z. Guy Harling Shahmanesh is supported by National Institutes of Health under award number 5R01MH114560-03, Bill & Melinda Gates Foundation, Grant Number OPP1136774 and OPP1171600. National Human Genome Research Institute of the National Institutes of Health (NIH) under Award Number U24HG006941, South African Medical Research Council (MRC-RFA-UFSP-01-2013/UKZN HIVEPI) and the South African Department of Science and Innovation (DSI). Tulio de Oliveira. Mark J. Siedner is supported by the National Institutes of Health (R01 AI124718, R01 AG059504). Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from the AHRI HDSS are publicly available upon request to the AHRI research repository which can be made here: https://data.africacentre.ac.za/index.php/auth/login/?destination=